Recent natural products based drug development: A pharmaceutical industry perspective

被引：318
|
作者：
Shu, YZ [1 ]
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
来源：
JOURNAL OF NATURAL PRODUCTS | 1998年 / 61卷 / 08期
关键词：
D O I：
10.1021/np9800102
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
[No abstract available]
引用
收藏
页码：1053 / 1071
页数：19
相关论文
共 50 条
  • [1] Natural products as catalysts for innovation: a pharmaceutical industry perspective
    Schmitt, Esther K.
    Moore, Charles M.
    Krastel, Philipp
    Petersen, Frank
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2011, 15 (04) : 497 - 504
  • [2] The impact of natural products on drug discovery in the pharmaceutical industry
    David, B.
    PLANTA MEDICA, 2007, 73 (09) : 802 - 802
  • [3] AQUACULTURE DRUG DEVELOPMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE
    BELEAU, MH
    VETERINARY AND HUMAN TOXICOLOGY, 1991, 33 : 11 - 13
  • [4] Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
    Murphy, Philip S.
    Bergstrom, Mats
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 957 - 965
  • [5] Pharmaceutical industry perspective on MPS technologies for drug development
    Gan, Jinping
    DRUG METABOLISM REVIEWS, 2016, 48 : 20 - 20
  • [6] NATURAL PRODUCTS IN PHARMACEUTICAL INDUSTRY
    BOHONOS, N
    PIERSMA, HD
    BIOSCIENCE, 1966, 16 (10) : 706 - +
  • [7] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING IN DRUG DISCOVERY AND DEVELOPMENT: A PHARMACEUTICAL INDUSTRY PERSPECTIVE
    Chen, Yuan
    Jones, Hannah
    Gibson, Christopher R.
    Heimbach, Tycho
    Parrott, Neil
    Peters, Sheila
    Snoeys, Jan
    Upreti, Vijay
    Zheng, Ming
    Hall, Stephen David
    DRUG METABOLISM REVIEWS, 2015, 47 : 105 - 106
  • [8] Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development: A Pharmaceutical Industry Perspective
    Jones, H. M.
    Chen, Y.
    Gibson, C.
    Heimbach, T.
    Parrott, N.
    Peters, S. A.
    Snoeys, J.
    Upreti, V. V.
    Zheng, M.
    Hall, S. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (03) : 247 - 262
  • [9] Role of population pharmacokinetics in drug development - A pharmaceutical industry perspective
    Samara, E
    Granneman, R
    CLINICAL PHARMACOKINETICS, 1997, 32 (04) : 294 - 312
  • [10] A PHARMACEUTICAL-INDUSTRY PERSPECTIVE ON DRUG LABELING
    ROBINSON, DS
    PSYCHOPHARMACOLOGY BULLETIN, 1994, 30 (01) : 23 - 25
12345